BioCentury
ARTICLE | Financial News

OrbiMed closes $924M royalty and credit fund

February 3, 2015 2:42 AM UTC

OrbiMed Advisors closed its second healthcare royalty and credit fund with $924 million. OrbiMed Royalty Opportunities II includes $900 million from institutional investors and $24 million from the fund's general partner.

The fund will acquire healthcare royalty streams and make structured investments, including combinations that incorporate debt and equity financings. The fund will commit $20-$150 million per investment and may collaborate with other OrbiMed funds to invest larger amounts. ...